These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29451)

  • 81. Effects of daily L-dopa administration on learning and brain structure in older adults undergoing cognitive training: a randomised clinical trial.
    Lebedev AV; Nilsson J; Lindström J; Fredborg W; Akenine U; Hillilä C; Andersen P; Spulber G; de Lange ECM; van den Berg DJ; Kivipelto M; Lövdén M
    Sci Rep; 2020 Mar; 10(1):5227. PubMed ID: 32251360
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys.
    Luan L; Ding F; Ai Y; Andersen A; Hardy P; Forman E; Gerhardt GA; Gash DM; Grondin R; Zhang Z
    Cell Transplant; 2008; 17(4):417-25. PubMed ID: 18522244
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Homeostatic regulation of dopaminergic neurons without dopamine.
    Surmeier DJ
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13103-4. PubMed ID: 15340144
    [No Abstract]   [Full Text] [Related]  

  • 84. Brain locations controlling the behavioral effects of chronic amphetamine intoxication.
    Hitzemann R; Wu J; Hom D; Loh H
    Psychopharmacology (Berl); 1980; 72(1):93-101. PubMed ID: 6162168
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 86. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.
    Creese I; Hess EJ
    Clin Neuropharmacol; 1986; 9 Suppl 4():14-6. PubMed ID: 2882838
    [No Abstract]   [Full Text] [Related]  

  • 87. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 88. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
    Ungerstedt U; Ljungberg T; Schultz W
    Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
    [No Abstract]   [Full Text] [Related]  

  • 90. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 92. Vascular dopamine receptor as a model for other dopamine receptors.
    Goldberg LI
    Adv Biochem Psychopharmacol; 1978; 19():119-29. PubMed ID: 358776
    [No Abstract]   [Full Text] [Related]  

  • 93. Two distinct classes of dopamine receptor mediating actions of antipsychotics: binding and behavioral studies.
    Sokoloff P; Martres MP; Protais P; Costentin J; Schwartz JC
    Adv Biochem Psychopharmacol; 1983; 36():163-73. PubMed ID: 6134435
    [No Abstract]   [Full Text] [Related]  

  • 94. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
    Costentin J
    Encephale; 1979; 5(2):121-49. PubMed ID: 38958
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.